Insider · CIK 0001801385
Kathryn Romano
officer
Files at KRYS (Krystal Biotech, Inc.). First filing Feb 28, 2025, latest Feb 28, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $131k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KRYS: Krystal Biotech, Inc.
KRYSOct 9, 2026 · close 331.61
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | Krystal Biotech, Inc. | $131k 750 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stock10b5-1 | -2,268 | $176.39 | $400k | 13,354 | Feb 28, 2025 |
| Feb 27, 2025 | KRYS Krystal Biotech, Inc. | SOpen-market sale Common Stock10b5-1 | -750 | $175.22 | $131k | 12,604 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $0.00 | $0 | 17,604 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stock10b5-1 | -2,315 | $179.25 | $415k | 15,289 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Common Stock10b5-1 | +7,500 | $0.00 | $0 | 22,789 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | FTax withholding Common Stock10b5-1 | -3,471 | $179.25 | $622k | 19,318 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Performance Stock Unitsderivative10b5-1 | -5,000 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | MOption exercise Performance Stock Unitsderivative10b5-1 | -7,500 | $0.00 | $0 | 7,500 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +10,000 | $0.00 | $0 | 10,000 | Feb 28, 2025 |
| Feb 28, 2025 | KRYS Krystal Biotech, Inc. | AGrant or award Restricted Stock Unitsderivative10b5-1 | +2,200 | $0.00 | $0 | 2,200 | Feb 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.